Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06622954
Status:
RECRUITING
Last Update Posted:
None
First Post:
2023-09-06
Brief Title:
Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Protein and Calorie Restriction as Treatment for Prevention of Cardiotoxicity in Women Receiving Chemotherapy
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROTECT-COR
Brief Summary:
The goal of this clinical trial is to compare a dietary intervention with a regular diet in patients with early breast cancer undergoing anthracycline based chemotherapy The main question it aims to answer is
What are the effects of a short-term diet with 30 caloric and 70 protein restriction PCR on cardiotoxicity induced by anthracycline treatment in women with newly diagnosed invasive breast cancer
Researchers will compare the control group with dietary intervention group to see if cardiotoxicity -measured by concentrations of high-sensitivity troponin T hsTnT levels- will be different between these two groups
What are the effects of a short-term diet with 30 caloric and 70 protein restriction PCR on cardiotoxicity induced by anthracycline treatment in women with newly diagnosed invasive breast cancer
Researchers will compare the control group with dietary intervention group to see if cardiotoxicity -measured by concentrations of high-sensitivity troponin T hsTnT levels- will be different between these two groups
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None